Top Markets
Coin of the day
Zenas BioPharma, Inc. Zenas BioPharma, Inc.

Zenas BioPharma, Inc.

ZBIO
Rang în acțiuni #6395
Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm,... Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm, concentrating on the creation and market introduction of innovative, immunology-based treatments. The company's primary investigational therapy is obexelimab, a distinctive bifunctional monoclonal antibody intended to address multiple diseases such as immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. Its developmental portfolio also features ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody. Established in 2019, the entity was formerly recognized as Zenas BioPharma (Cayman) Limited before adopting its current name, Zenas BioPharma, Inc., in August 2023. Its headquarters are located in Waltham, Massachusetts.
Preț acțiune
$33.00
Capitalizare de piață
$2.08B
Schimbare (1 zi)
-0.12%
Schimbare (1 an)
97.49%
Țară
US
Tranzacționează Zenas BioPharma, Inc. (ZBIO)

Categorie

Istoricul spliturilor pentru Zenas BioPharma, Inc. (ZBIO)
Acțiunea Zenas BioPharma, Inc. (simbol: ZBIO) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 27, 2026.
O acțiune ZBIO cumpărată înainte de Aug 27, 2026 este echivalentă astăzi cu 0 acțiuni ZBIO.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH